Epigenetic reprogramming is a process by which epigenetic modifications are altered, leading to changes in gene expression without changing the underlying DNA sequence. This process is important for normal development, but can also be used to reprogram cells and alter their fate. Epigenetic reprogramming can be achieved through various molecular mechanisms such as DNA methylation, histone modification, and non-coding RNA-mediated regulation. The process of epigenetic reprogramming is thought to be a key mechanism of plasticity during development and in response to environmental stimuli. It plays a role in the regulation of gene expression and can be used to reprogram cells from one type to another. For example, it has been used to reprogram adult cells into induced pluripotent stem cells (iPSCs) which have the potential to differentiate into any cell type in the body. Epigenetic reprogramming is also involved in diseases such as cancer and neurological disorders. Aberrant epigenetic reprogramming can lead to changes in gene expression that can contribute to the development of these diseases. This has led to increasing interest in epigenetic therapies which target epigenetic modifications to correct abnormal gene expression.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia